Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/196477
Type: Artigo de periódico
Title: Biomarker Analysis In Carcinoma Ex Pleomorphic Adenoma At An Early Phase Of Carcinomatous Transformation.
Author: Freitas, Leandro L L
Araújo, Vera C
Martins, Marilia T
Chone, Carlos
Crespo, Agricio
Altemani, Albina
Abstract: Diagnostic criteria for intracapsular carcinoma ex pleomorphic adenoma (CXPA) are subjective and vary among authors. Biomarker analysis, which could provide more objective evaluation of these tumors, has rarely been studied in intracapsular CXPA. Immunohistochemical evaluation of c-erbB-2, p53 protein, bcl-2, and Ki-67 was performed in 8 cases of CXPA at an early phase of malignant transformation (4 intracapsular and 4 minimally invasive) and in 17 pleomorphic adenomas (PA). In all cases of CXPA, p53 and Ki-67 were demonstrated predominantly in luminal cells of benign and malignant areas, significantly more in the latter. Few benign myoepithelial cells were p53 positive. c-erbB-2 reactivity was strongly associated with atypical luminal cells. Bcl-2 expression was weak and focal in malignant areas from 2 cases. In conclusion, both p53 and c-erbB-2 proteins appear to be involved at an early stage of malignization of PA. In PA with atypical cells, evaluation of the expression of these 2 markers provides more objective criteria for the diagnosis of intracapsular CXPA.
Subject: Adenoma, Pleomorphic
Adult
Aged
Cell Transformation, Neoplastic
Female
Humans
Immunohistochemistry
Ki-67 Antigen
Male
Middle Aged
Neoplasm Staging
Parotid Neoplasms
Proto-oncogene Proteins C-bcl-2
Receptor, Erbb-2
Submandibular Gland Neoplasms
Tumor Markers, Biological
Tumor Suppressor Protein P53
Rights: fechado
Identifier DOI: 
Address: http://www.ncbi.nlm.nih.gov/pubmed/16273189
Date Issue: 2005
Appears in Collections:Artigos e Materiais de Revistas Científicas - Unicamp

Files in This Item:
File SizeFormat 
pmed_16273189.pdf5.02 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.